Trials / Conditions / Lymphatic Malformation

Lymphatic Malformation

17 registered clinical trials studyying Lymphatic Malformation — 10 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Diagnostic Imaging of Vascular Malformations Using MSOT and ULM NCT06994260	University Hospital Erlangen	—
Recruiting	Different Doses of Sirolimus for the Treatment of Cystic Lymphatic Malformations NCT06673290	West China Hospital	Phase 2 / Phase 3
Recruiting	A Trial of Targeted Therapies for Patients With Slow-Flow or Fast-Flow Vascular Malformations NCT05983159	Murdoch Childrens Research Institute	Phase 2
Recruiting	Institution of an Italian Registry and Biobank for Biological Sample Collection NCT06892964	Fondazione Policlinico Universitario Agostino Gemelli IRCCS	N/A
Recruiting	Safety and Efficacy Study of Intracystic TARA-002 for the Treatment of Lymphatic Malformations in Participants NCT05871970	Protara Therapeutics	Phase 2
Recruiting	Use of Bleomycin in the Sclerotherapy of Lymphatic Malformations for Pediatric Patients NCT06437158	West China Hospital	Phase 2
Completed	National Evaluation of Patients With PIK3CA-Related Overgrowth Spectrum (PROS) NCT05563831	Institut National de la Santé Et de la Recherche Médicale, France	—
Recruiting	A Prospective Study on the Treatment of cLM Based on ICG Imaging NCT06275022	Nanjing Children's Hospital	N/A
Recruiting	Weekly Sirolimus Therapy NCT04861064	Medical University of South Carolina	Phase 2
Withdrawn	A Pharmacokinetic, Pharmacodynamic, Safety and Tolerability Study of CERC-006 in Adults With Complex Lymphatic NCT04994002	Avalo Therapeutics, Inc.	Phase 1
Completed	Vascular Anomaly Pathology and Genomics Biopsy Study NCT04836884	Mayo Clinic	N/A
Terminated	First in Human Trial of Topical VT30 in Pts With Venous/Lymphatic Malformations Assoc With PIK3CA or TEK Gene NCT04409145	Venthera, Inc., a BridgeBio company	Phase 1 / Phase 2
Completed	Topical Sirolimus in Cutaneous Lymphatic Malformations NCT03972592	University Hospital, Tours	Phase 2
Completed	Indocyanine Green Lymphography in Management of Lingual Lymphatic Malformation NCT06755905	Nanjing Children's Hospital	N/A
Recruiting	Efficacy of Rapamycin in the Treatment of Cervico-facial Lymphatic Malformations NCT03243019	University Hospital, Lille	Phase 2
Recruiting	Lymphatic Anomalies Registry for the Assessment of Outcome Data NCT02399527	Boston Children's Hospital	—
Completed	Clinical Characteristics of Lymphatic Malformations NCT06257719	West China Hospital	—